Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
117.46
+0.06 (+0.05%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
71
72
Next >
Why Prometheus Biosciences Stock Is Skyrocketing This Week
April 20, 2023
There's nothing like a big buyout to send a clinical-stage biotech stock soaring higher.
Via
The Motley Fool
Why Shares of Bellus Health Skyrocketed This Week
April 20, 2023
The company has received a buyout offer from GSK.
Via
The Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
Two key tailwinds fueled a surge in the biotech's share price this week.
Via
The Motley Fool
These 2 Growth Stocks Might Be Incredibly Undervalued Right Now
April 20, 2023
These two biopharma stocks could be poised for a major growth spurt.
Via
The Motley Fool
Is Moderna About to Face the Same Challenge as Other Biotechs?
April 20, 2023
Investors have gotten used to Moderna's rapid vaccine development.
Via
The Motley Fool
This Is What Whales Are Betting On Merck & Co
April 19, 2023
Via
Benzinga
Genprex Touts Encouraging Preclinical Data From Lung Cancer Candidate
April 19, 2023
Genprex Inc (NASDAQ: GNPX) announced that its research collaborators presented preclinical data for the NPRL2 gene (also known as the TUSC4 gene).
Via
Benzinga
Is Merck Stock a Screaming Buy After This $11 Billion Acquisition?
April 19, 2023
Merck's move into immunology is a risky proposition.
Via
The Motley Fool
Why BELLUS Health Stock Is Rocketing Higher Today
April 18, 2023
A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.
Via
The Motley Fool
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
April 18, 2023
Shares of its takeover candidate nearly doubled on the news.
Via
Investor's Business Daily
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
April 18, 2023
On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.
Via
Benzinga
Tesla, Windtree Therapeutics, Enovix Corp, Moderna, Blackboxstocks: Why These 5 Stocks Are Drawing Investors' Attention Today
April 17, 2023
Via
Benzinga
These 2 Stocks Were Monday's Big Disappointments
April 17, 2023
On a good day for the market, investors weren't happy about these decliners.
Via
The Motley Fool
S&P 500: Top 5 Performers Today Include Enphase Energy, First Solar
April 17, 2023
M&T Bank was the S&P 500's top performer. State Street was the biggest loser.
Via
Investor's Business Daily
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
April 17, 2023
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.
Via
The Motley Fool
Wall Street Analysts Are Bullish On Moderna Stock Price: Should You?
April 17, 2023
Moderna and Merck announced positive results of its cancer vaccine. The vaccine together with Keytruda helped patients stay cancer free for 18 months. Wall Street analysts are bullish on Moderna...
Via
Talk Markets
Why Shares of Prometheus Biosciences Are Soaring Monday
April 17, 2023
Merck's $10.8 billion buyout offer sent the clinical-stage biotech stock higher.
Via
The Motley Fool
Moderna Crumbles As Cancer Vaccine Data Shows A 'Longish And Complex' Road
April 17, 2023
The path to approval isn't necessarily clear cut, according to multiple analysts.
Via
Investor's Business Daily
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
April 17, 2023
Merck is branching into immune-mediated diseases with this takeover.
Via
Investor's Business Daily
Moderna (MRNA) Stock Sinks Despite Positive Cancer Vaccine Update
April 17, 2023
MRNA stock is sinking this morning despite Moderna releasing positive Phase 2b data on its mRNA cancer vaccine yesterday.
Via
InvestorPlace
RXDX Stock Alert: The $10.8 Billion Reason Prometheus Biosciences Is Surging Today
April 17, 2023
RXDX stock is soaring today as Merck is officially acquiring Prometheus Biosciences. Here's what investors should know today.
Via
InvestorPlace
XPeng Is Charging Higher, but This Biotech Stock Is Monday's Biggest Winner
April 17, 2023
Markets are watching corporate earnings very carefully.
Via
The Motley Fool
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
April 17, 2023
Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK).
Via
InvestorPlace
Moderna, Merck's Cancer Vaccines Exhibit Positive Outcomes Under Midstage Trial
April 17, 2023
Via
Benzinga
What's Going On With Moderna Stock Monday?
April 17, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading higher Monday after the company presented data with Merck & Company Inc (NYSE: MRK) showing mRNA-4157 in combination with KEYTRUDA reduced the risk of r
Via
Benzinga
Merck Acquires Prometheus Biosciences For $10.8B, Strengthening Its Immunology Pipeline
April 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 17, 2023
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
Nasdaq, S&P 500 Futures Muted; Analyst Says Don't Expect Good News This Earnings Season
April 17, 2023
Early indications suggest that stocks could start the week on a tentative note, which was characteristic of trading during most of last week. Traders may show restraint as they look ahead to...
Via
Benzinga
Moderna, Merck, And A Personalized Cancer Vaccine: What Does Their AACR Presentaion Tell Us?
April 16, 2023
Moderna and Merck presented additional data on their personalize cancer vaccine. Is this a true breakthrough in cancer vaccines?
Via
Talk Markets
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Sunday, April 16
April 16, 2023
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of April 10-14.
Via
Talk Markets
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
71
72
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.